Mediastinoscopic ultrasonography (MUS)

Area of Science:

• Thoracic Surgery
• Diagnostic Imaging
• Oncology

Background:

• Accurate pre-therapeutic T4 staging is crucial for central lung cancer management, guiding neoadjuvant therapy and surgical decisions.
• Current non-invasive imaging techniques like CT and NMR have limited accuracy, while transesophageal endoscopy (TEE) is hindered by airway interference.
• Existing methods often fail to provide definitive staging for centrally located lung tumors, impacting treatment planning.

Purpose of the Study:

• To introduce and evaluate a novel imaging technique, mediastinoscopic ultrasonography (MUS), for enhanced T4 staging of central lung cancers.
• To assess the feasibility and accuracy of MUS in visualizing mediastinal structures and tumor invasion.
• To determine if MUS can improve upon existing imaging modalities for staging central lung tumors.

Main Methods:

• Development and application of mediastinoscopic ultrasonography (MUS), utilizing a fingertip ultrasound probe inserted via a video-mediastinoscope.
• MUS probe positioned anterior to the tracheo-bronchial tree, enabling direct contact with the vena cava and pulmonary artery.
• Pilot study involving 12 patients with centrally located lung cancer to assess visualization and staging accuracy.

Main Results:

• MUS provided excellent, artifact-free visualization of central vessels and their relationship to the tumor in all 12 patients.
• In 3 patients, MUS findings contradicted the T4 stage predicted by CT scan, leading to altered treatment strategies.
• These 3 patients proceeded to successful pneumonectomy (R0 resection), while the remaining 9 received induction therapy.

Conclusions:

• Mediastinoscopic ultrasonography (MUS) is a promising new technique for accurate T4 staging of centrally located lung cancers.
• MUS overcomes limitations of CT, NMR, and TEE by providing clear visualization of critical mediastinal structures.
• This technique has the potential to refine treatment decisions and improve surgical outcomes for patients with central lung tumors.